IAMOG
DGX icon

Investors Asset Management of Georgia’s Quest Diagnostics DGX Stock Holding History

Investors Asset Management of Georgia’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-70
Closed -$9K – 271
2022
Q3 		$9K Hold
70
– – ﹤0.01% 481
2022
Q2 		$9K Buy
+70
New +$9.54K ﹤0.01% 422

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Investors Asset Management of Georgia's DGX Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 70 shares — an estimated $9K sold.

Investors Asset Management of Georgia first reported a position in DGX in Q2 2022 and held it in 2 quarters. The position peaked at $9K in Q3 2022. 880 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Investors Asset Management of Georgia reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 70 Quest Diagnostics shares in Q4 2022, an estimated $9K.
  • Investors Asset Management of Georgia first reported a position in Quest Diagnostics in Q2 2022 and held it in 2 quarters.
  • Investors Asset Management of Georgia's Quest Diagnostics position peaked at $9K in Q3 2022.
  • 880 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.